Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06975085

Completed

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

Breast Cancer Female
NCT02308085

Active, not recruiting

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)

Early Breast Cancer
NCT02747004

Active, not recruiting

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (Next MONARCH 1)

Metastatic Breast Cancer
NCT02122107

Active, not recruiting

Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History

Breast Cancer Survivors
NCT03121469

Completed

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer (RPOS+)

Localized Breast Cancer
NCT02653755

Active, not recruiting

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

Breast Cancer Radiation
NCT00314405

Completed

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

Infiltrative Breast Cancer
NCT03676257

Completed

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

Metastatic Breast Cancer
NCT06362993

Active, not recruiting

Breast Cancer Screening in Ghana

Breast Cancer Female
NCT04565054

Active, not recruiting

Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC (ADAPTlate)

Breast Cancer Female
NCT04272801

Active, not recruiting

Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer (POWER)

Breast Cancer Female
NCT03313908

Completed

Radioguided Occult Lesion Localisation by Indocyanine Green (ROLL-1)

Breast Cancer Female
NCT04126525

Active, not recruiting

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer (NeoATP)

Breast Cancer Female
NCT02423902

Terminated

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer

Metastatic Breast Cancer
NCT04756765

Withdrawn

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer
NCT07064317

Completed

Catheter Tip Position and Contrast Distribution Following Paravertebral Catheter Insertion: a CT Study

Breast Cancer Patients
NCT06412341

Completed

Feasibility Study of ABC for Women Treated for Breast Cancer

Breast Cancer Female
NCT01726322

Terminated

Ovarian Reserve in Premenopausal Breast Cancer

Breast Cancer | Premenopausal Breast Cancer
NCT03219476

Completed

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Breast Cancer | Invasive Breast Cancer
NCT06926088

Active, not recruiting

Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer (CAMELIA)

Advanced Breast Cancer
NCT01916317

Active, not recruiting

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Operable Breast Cancer
NCT05923177

Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Primary Breast Cancer
NCT05923268

Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Breast Cancer Female
NCT02310698

Completed

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

Breast Cancer Screening
NCT05303129

Completed

Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor. (PEPSI)

Breast Cancer | Metastatic Breast Cancer
NCT05176080

Terminated

Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Metastatic Breast Cancer
NCT06098118

Completed

Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

Breast Cancer Screening
NCT01084863

Completed

Evaluate Safety, Efficacy and Pharmacokinetics (Compare)

Metastatic Breast Cancer
NCT01957332

Active, not recruiting

IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer (IMPACT-MBC)

Metastatic Breast Cancer
NCT03901339

Completed

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer (TROPiCS-02)

Metastatic Breast Cancer
NCT05012644

Completed

Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

Metastatic Breast Cancer
NCT02028507

Completed

Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors (PEARL)

Metastatic Breast Cancer
NCT02913430

Completed

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

Metastatic Breast Cancer
NCT04950010

Terminated

High-intensity Exercise After Treatment (HEAT)

Breast Cancer | Breast Neoplasm Female
NCT03980626

Completed

Study on Physical Activity's Relationship With Cancer and Cognition (SPARCC)

Breast Cancer | Breast Neoplasm Female
NCT04176354

Completed

Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy

Metastatic Breast Cancer
NCT06531135

Enrolling by invitation

A RCT of Psychosocial Interventions Facilitating Positive Psychological Adaptation in Breast Cancer

Breast Cancer Female
NCT05283837

Completed

A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)

Metastatic Breast Cancer
NCT06500936

Completed

Evaluation of an mHealth Intervention to Promote Participation in Breast Cancer Screening in Argentina

Breast Cancer Screening
NCT04655573

Terminated

A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer

Advanced Breast Cancer
NCT02448420

Completed

Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer (PATRICIA II)

Metastatic Breast Cancer
NCT03703466

Completed

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT05000502

Completed

Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations (EMBRACE)

Female Breast Cancer
NCT03322215

Terminated

HR+/HER2- Advanced Breast Cancer and Endocrine Resistance (PASIPHAE)

Breast Cancer Metastatic
NCT05695859

Completed

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy

Breast Cancer Female
NCT05821023

Completed

Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women

Breast Cancer Screening
NCT03564782

Completed

Examining Bioactivity of PVSRIPO in Invasive Breast Cancer

Invasive Breast Cancer
NCT05155566

Completed

Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

Breast Cancer Metastatic
NCT03005860

Withdrawn

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

Female Breast Cancer
NCT04714619

Terminated

CB-103 Plus NSAI In Luminal Advanced Breast Cancer (CAILA)

Advanced Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations